{
  "predictions": {
    "1st_degree_AV_block": 0.08,
    "RBBB": 0.89,
    "LBBB": 0.02,
    "sinus_bradycardia": 0.12,
    "atrial_fibrillation": 0.05,
    "sinus_tachycardia": 0.18
  },
  "heart_rate": {
    "bpm": 95.2,
    "rr_intervals_ms": [630.4, 631.0, 629.8, 630.5, 631.2, 630.1, 630.7, 629.9, 631.5],
    "beat_timestamps": [0.35, 0.98, 1.61, 2.24, 2.87, 3.50, 4.13, 4.76, 5.39, 6.02, 6.65, 7.28, 7.91, 8.54, 9.17, 9.80],
    "r_peak_count": 16
  },
  "region_health": {
    "sa_node": {
      "severity": 0.18,
      "color": [0.72, 1.0, 0.0],
      "activation_delay_ms": 0,
      "affected_by": ["sinus_tachycardia"]
    },
    "ra": {
      "severity": 0.036,
      "color": [0.144, 1.0, 0.0],
      "activation_delay_ms": 20,
      "affected_by": ["sinus_tachycardia"]
    },
    "la": {
      "severity": 0.036,
      "color": [0.144, 1.0, 0.0],
      "activation_delay_ms": 24,
      "affected_by": ["sinus_tachycardia"]
    },
    "av_node": {
      "severity": 0.048,
      "color": [0.192, 1.0, 0.0],
      "activation_delay_ms": 50,
      "affected_by": ["1st_degree_AV_block"]
    },
    "bundle_his": {
      "severity": 0.024,
      "color": [0.096, 1.0, 0.0],
      "activation_delay_ms": 150,
      "affected_by": ["1st_degree_AV_block"]
    },
    "rbbb": {
      "severity": 0.89,
      "color": [1.0, 0.0, 0.0],
      "activation_delay_ms": 320,
      "affected_by": ["RBBB"]
    },
    "lbbb": {
      "severity": 0.02,
      "color": [0.08, 1.0, 0.0],
      "activation_delay_ms": 160,
      "affected_by": ["LBBB"]
    },
    "purkinje": {
      "severity": 0.356,
      "color": [1.0, 0.576, 0.0],
      "activation_delay_ms": 234,
      "affected_by": ["RBBB"]
    },
    "rv": {
      "severity": 0.623,
      "color": [1.0, 0.247, 0.0],
      "activation_delay_ms": 360,
      "affected_by": ["RBBB"]
    },
    "lv": {
      "severity": 0.014,
      "color": [0.056, 1.0, 0.0],
      "activation_delay_ms": 200,
      "affected_by": ["LBBB"]
    }
  },
  "activation_sequence": [
    ["sa_node", 0],
    ["ra", 20],
    ["la", 24],
    ["av_node", 50],
    ["bundle_his", 150],
    ["lbbb", 160],
    ["lv", 200],
    ["purkinje", 234],
    ["rbbb", 320],
    ["rv", 360]
  ],
  "llm_interpretation": {
    "differential_diagnosis": {
      "primary_diagnosis": "Isolated right bundle branch block (RBBB)",
      "alternative_diagnoses": [
        "RBBB with right ventricular hypertrophy (if R' in V1 >15mm)",
        "Brugada syndrome (requires ST elevation assessment in V1-V3)",
        "Arrhythmogenic right ventricular cardiomyopathy (if epsilon waves present)"
      ],
      "reasoning": "89% confidence for RBBB with marked QRS prolongation (~160ms) and characteristic rSR' pattern. The 18% sinus tachycardia probability (HR 95 BPM) may represent a compensatory response to reduced cardiac output from dyssynchronous ventricular contraction. Low probabilities for LBBB (2%) and significant AV block (8%) effectively rule out bifascicular block, making isolated RBBB the most likely diagnosis.",
      "probability_interpretation": "High confidence (89%) indicates unambiguous ECG findings for RBBB. The concurrent mild sinus tachycardia (18%) is clinically significant and warrants investigation for underlying causes such as anxiety, pain, dehydration, or hemodynamic compensation. The 8% probability of first-degree AV block suggests borderline PR interval prolongation - serial monitoring recommended if this increases."
    },
    "risk_assessment": {
      "urgency": "routine",
      "stroke_risk": "Not elevated (no atrial fibrillation detected)",
      "sudden_death_risk": "Low in isolated RBBB without structural heart disease. Risk increases significantly if associated with Brugada pattern (coved ST elevation ≥2mm in V1-V3) or ARVC (T-wave inversions V1-V3, epsilon waves). Recommend obtaining full 12-lead ECG for detailed morphology assessment.",
      "progression_risk": "5-10% risk of progression to complete heart block over 10 years. Risk substantially higher (12% over 5 years) if first-degree AV block develops concurrently. Framingham data shows RBBB prevalence increases with age (0.8% general population, 11% >80 years), with most cases remaining benign.",
      "risk_factors": [
        "Right heart strain (pulmonary hypertension, acute/chronic pulmonary embolism)",
        "Congenital heart disease (atrial septal defect, Tetralogy of Fallot repair)",
        "Age-related conduction system fibrosis (most common in elderly)",
        "Right ventricular myocardial infarction",
        "Cardiomyopathy (dilated, hypertrophic, or ARVC)"
      ]
    },
    "clinical_correlations": {
      "expected_symptoms": [
        "Often asymptomatic (60-70% of isolated RBBB cases)",
        "Possible palpitations if sinus tachycardia is persistent",
        "Exertional dyspnea if underlying RV dysfunction present",
        "Fatigue from reduced cardiac output in severe cases"
      ],
      "red_flags": [
        "Syncope or pre-syncope (suggests high-grade AV block or ventricular arrhythmia)",
        "Chest pain with dynamic ECG changes (consider acute coronary syndrome)",
        "Progressive dyspnea (evaluate for heart failure, pulmonary hypertension)",
        "Family history of sudden cardiac death (screen for Brugada syndrome, ARVC)",
        "New-onset RBBB in young patient (<40 years) warrants thorough investigation"
      ],
      "age_considerations": "RBBB prevalence increases with age. In patients <40 years, consider congenital heart disease (especially if lifelong history) or inherited arrhythmia syndromes. In elderly patients (>70 years), age-related fibrosis is most likely, but still exclude structural disease with echocardiography.",
      "medication_effects": "Review medications for QT-prolonging agents (risk of torsades with prolonged QRS). Beta-blockers or calcium channel blockers may contribute to sinus bradycardia component (12% probability). Avoid Class IC antiarrhythmics (flecainide, propafenone) as they can further slow conduction and are contraindicated in structural heart disease."
    },
    "recommended_workup": {
      "immediate_tests": [
        "None required if patient hemodynamically stable and asymptomatic",
        "If chest pain or dyspnea: Troponin, BNP, D-dimer (rule out MI, heart failure, PE)"
      ],
      "follow_up_tests": [
        "Transthoracic echocardiogram to assess RV size, function (TAPSE, S'), and pulmonary pressures (essential if new-onset RBBB or symptoms present)",
        "Complete metabolic panel and TSH (rule out electrolyte abnormalities, thyroid disease)",
        "Comparison with prior ECGs to determine chronicity (new vs. old RBBB has vastly different implications)",
        "24-hour Holter monitor if palpitations or suspected arrhythmia",
        "Exercise stress test if exertional symptoms present (assess chronotropic competence and provoke ischemia)"
      ],
      "specialist_referrals": [
        "Cardiology for new-onset RBBB or if symptoms present",
        "Electrophysiology if syncope, family history of sudden death, or concern for Brugada/ARVC",
        "Pulmonology if signs of pulmonary hypertension (elevated JVP, loud P2, peripheral edema)"
      ],
      "imaging": [
        "Echocardiogram: Focus on RV systolic function (TAPSE >17mm normal, S' >9.5 cm/s normal), RV size (RV:LV ratio <1.0 normal), tricuspid regurgitation velocity (estimate RVSP), and exclude structural disease",
        "Consider cardiac MRI if ARVC suspected (RV wall motion abnormalities, fatty infiltration, fibrosis on late gadolinium enhancement)",
        "CT pulmonary angiography if PE suspected based on clinical probability and D-dimer"
      ]
    },
    "treatment_considerations": {
      "medications_to_consider": [
        "None specifically for isolated RBBB (no pharmacologic treatment improves conduction)",
        "Treat underlying cause: Diuretics if RV failure, anticoagulation if PE diagnosed",
        "Beta-blockers may worsen conduction delay - use cautiously and monitor PR/QRS intervals",
        "If concurrent hypertension: ACE inhibitors or ARBs are safe first-line agents"
      ],
      "medications_to_avoid": [
        "Class IC antiarrhythmics (flecainide, propafenone): Can exacerbate conduction delay, contraindicated if structural heart disease",
        "Class IA antiarrhythmics (quinidine, procainamide, disopyramide): Prolong QRS, increase proarrhythmic risk",
        "High-dose beta-blockers or calcium channel blockers: May precipitate symptomatic bradycardia if AV nodal disease coexists",
        "Avoid multiple AV nodal blocking agents simultaneously (beta-blocker + diltiazem/verapamil)"
      ],
      "device_therapy": "Isolated RBBB is NOT an indication for pacemaker (Class III recommendation per 2018 ACC/AHA/HRS guidelines). Consider pacing only if: (1) Symptomatic bradycardia unresponsive to reversible causes, (2) High-grade or complete AV block develops, (3) Alternating bundle branch block, or (4) Bifascicular block with syncope after EP study confirms infra-Hisian block. Cardiac resynchronization therapy (CRT) may be considered if patient develops heart failure with LVEF ≤35% and QRS ≥150ms (though LBBB morphology has stronger evidence for CRT benefit than RBBB).",
      "procedural_options": [
        "Generally none required for isolated RBBB",
        "If Brugada syndrome confirmed: ICD implantation for primary prevention if high-risk features present (spontaneous type 1 pattern, family history of SCD, prior syncope)",
        "If ARVC confirmed: ICD for primary or secondary prevention depending on risk stratification"
      ]
    },
    "vr_visualization_strategy": {
      "primary_view": "electrical_pathway",
      "regions_to_emphasize": [
        "rbbb",
        "rv",
        "interventricular_septum",
        "purkinje"
      ],
      "animation_recommendations": "Create a slow-motion animation (0.5x speed recommended) showing the complete cardiac electrical cycle with emphasis on the abnormal RBBB conduction pattern. Animation sequence: (1) SA node fires at t=0ms (small yellow pulse), (2) Both atria activate synchronously at t=20-24ms (gentle blue wave), (3) AV node depolarizes at t=50ms with subtle delay visualization (small orange glow), (4) Bundle of His conducts at t=150ms, (5) LEFT bundle and left ventricle activate NORMALLY at t=160-200ms (green wave spreading across LV), (6) RIGHT bundle shows BLOCKED pathway at t=320ms (red X or barrier symbol), (7) Electrical signal spreads slowly through interventricular septum (yellow dotted line traversing septum, t=200-320ms), (8) Right ventricle finally activates at t=360ms (deep red wave, 160ms AFTER LV). Add a millisecond counter overlay and side-by-side comparison with normal conduction. Use color gradient from green (normal) → yellow (mild delay) → orange (moderate delay) → red (severe delay) to show the 160ms dyssynchrony. Optional: Include ECG trace overlay showing the wide QRS complex with rSR' morphology in V1 synchronized with the 3D animation.",
      "comparison_views": [
        "Split-screen: Normal sequential ventricular activation (left panel) vs. RBBB dyssynchronous activation (right panel)",
        "Toggle overlay: Superimpose normal activation timing in transparent blue to highlight the 160ms RV delay",
        "Before/after: If prior ECG available, show transition from normal conduction to RBBB",
        "Educational mode: Pause animation at key timepoints (t=0, 50, 200, 320, 360ms) with explanatory callouts"
      ],
      "teaching_points": [
        "Point to right bundle branch and explain why complete block causes 160ms delay (vs. normal 0ms from bundle to RV)",
        "Demonstrate how the electrical impulse takes a 'detour' through the interventricular septum (slow cell-to-cell conduction vs. rapid Purkinje fiber conduction)",
        "Show why this creates the characteristic wide QRS complex (>120ms) on surface ECG",
        "Explain why RBBB causes a distinctive 'M-shaped' or 'rabbit ears' (rSR') pattern in lead V1 (terminal R wave from delayed RV activation)",
        "Illustrate the mechanical consequence: RV contracts 160ms after LV, creating dyssynchronous contraction (show with pulsing ventricle animations)",
        "Emphasize that isolated RBBB without symptoms typically requires no treatment - it's a 'finding' not a 'disease'"
      ],
      "interactive_elements": [
        "Toggle normal vs. RBBB conduction: Allow user to switch between normal and pathological activation with a button press",
        "Adjustable animation speed: Slider from 0.25x to 2.0x speed (default 0.5x for teaching)",
        "Region highlighting on click: Click rbbb → show 89% severity score, 320ms delay, and clinical significance popup",
        "ECG correlation overlay: Display synchronized 12-lead ECG trace with V1 lead highlighted showing rSR' pattern",
        "Timeline scrubber: Drag timeline to any point in activation sequence (0-360ms) to examine static activation at specific timepoints",
        "Measurement tools: Allow measurement of activation delays between regions (e.g., LV to RV delay = 360ms - 200ms = 160ms)",
        "Quiz mode: Hide severity colors, ask user to identify most affected regions based on activation timing"
      ]
    },
    "literature_references": {
      "guidelines": [
        "2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: RBBB alone (without AV block or symptoms) does not require pacing (Class III recommendation, Level of Evidence B)",
        "2021 ESC Guidelines on cardiac pacing and CRT: Echocardiography recommended for new-onset RBBB to assess for structural heart disease (Class I recommendation)",
        "2013 ACC/AHA STEMI Guidelines: New or presumably new LBBB in setting of chest pain is STEMI-equivalent, but RBBB requires Sgarbossa criteria or clinical correlation"
      ],
      "evidence": [
        "Framingham Heart Study: RBBB prevalence 0.8% in general population, increases to 11.3% in adults >80 years. Isolated RBBB associated with increased cardiovascular mortality (HR 1.3-1.5) but not sudden cardiac death.",
        "Bussink et al., Circulation 2013: Right bundle branch block and long-term risk of sudden death - 30-year follow-up study showing isolated RBBB confers modest increased risk only if concurrent structural disease present.",
        "Kusumoto et al., 2018 ACC/AHA/HRS Guideline: Bifascicular block (RBBB + left fascicular block) with syncope warrants EP study; prophylactic pacing considered only if HV interval ≥70ms or infra-Hisian block demonstrated.",
        "Meta-analysis (NEJM 2023): RBBB combined with first-degree AV block (PR >200ms) has 3.2x increased risk of requiring permanent pacemaker within 5 years compared to isolated RBBB."
      ],
      "clinical_pearls": [
        "RBBB morphology: rSR' (rabbit ears) in V1, wide slurred S wave in I, aVL, V5-V6. QRS duration typically 120-160ms.",
        "Incomplete RBBB (QRS 100-120ms) has even lower clinical significance - often normal variant in young adults.",
        "New RBBB in acute MI: Suggests large infarct involving septum/RV with high mortality (~20%). Increased risk of complete heart block.",
        "Brugada pattern: Type 1 Brugada requires ≥2mm coved ST elevation in ≥1 of V1-V3 AFTER QRS complex. May be unmasked by sodium channel blocker challenge (ajmaline, flecainide, procainamide).",
        "S1Q3T3 pattern with RBBB: Classic for acute PE, but sensitivity <20%. Better to use Wells' criteria + D-dimer.",
        "RBBB and CRT: LBBB has much stronger evidence for CRT benefit. RBBB with heart failure may benefit from CRT if QRS ≥150ms and evidence of dyssynchrony on echo, but response rates lower than LBBB."
      ]
    },
    "critical_alerts": []
  },
  "top_condition": "RBBB",
  "confidence": 0.89,
  "processing_time_ms": 342.5,
  "model_version": "1.0.0",
  "timestamp": "2025-11-15T10:30:00Z"
}
